Dapsone 6% / Niacinamide 2% / Spironolactone 5%
Product Images NDC 72934-1061

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Dapsone 6% / Niacinamide 2% / Spironolactone 5% (NDC 72934-1061). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sincerus Florida, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

D (2 End)

FDA Label Image

Sf (1061 2 Front)

Sf (1061 2 Front)
This appears to be a label for a medication, specifically a topical gel containing 6% dapsone, 2% niacinamide, and 5% spironolactone. The label also provides information on the size of the container (30 grams) and the National Drug Code (NDC) for the medication (72934-1061-2). The remaining text is illegible or appears to be an error in the process.*
FDA Label Image

S (1061 2 Middle)

S (1061 2 Middle)
This appears to be a medication prescription with the lot number O11503ABCDERGHE@, with an expiration date of 01/01/1970. The medication contains active ingredients such as Dapsone, Niacinamide, and Spironolactone. The inactive ingredients include Butylated Hydroxytoluene, Lavender Oil, Propylene Glycol, and Suspendisse Gel.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.